SECTION I - INFECTIOUS AGENT


NAME: Streptobacillus moniliformis

SYNONYM OR CROSS REFERENCE: Streptobacilliosis, Streptobacillary fever, Haverhill fever, Epidemic arthritic erythema; Rat-bite fever due to Streptobacillus moniliformis.

CHARACTERISTICS: Non-encapsulated, non-motile, gram-negative bacillus, 0.3-0.7 um by 1-5 um in length; organism frequently occurs in chains and filaments; often pleomorphic and produces a series of bulbous swelling; facultative anaerobe.

SECTION II - HEALTH HAZARD

PATHOGENICITY: Abrupt onset of fever, chills, vomiting, headache and severe pains in the joints; a maculopapular rash develops within the first 48 hours and involves the palms, soles and extremities; acute arthritis is a characteristic and persistent symptom; multiple abscesses in many organs is typical of the severe form of the disease .

EPIDEMIOLOGY: World wide; uncommon in North and South America and most European countries; cases in USA were mostly due to exposure to laboratory rats.

HOST RANGE: Humans, rats.

INFECTIOUS DOSE: Not known.

MODE OF TRANSMISSION: By direct contact with secretions of the mouth, nose, eye of an infected animal; animal bite; contaminated milk has been suspected as the vehicle of infection in an outbreak.

INCUBATION PERIOD: Usually 3-10 days.

COMMUNICABILITY: Not directly transmitted from person-to-person.

SECTION III - DISSEMINATION

RESERVOIR: Rats.


ZOONOSIS: Yes - disease acquired from rats.


VECTORS: None.

SECTION IV - VIABILITY

DRUG SUSCEPTIBILITY: Sensitive to penicillin, tetracycline.

SUSCEPTIBILITY TO DISINFECTANTS: Susceptible to 70% ethanol, 1% sodium hypochlorite (20% commercial bleach), 2% glutaraldehyde.

PHYSICAL INACTIVATION: Heating at 121o C for 15 minutes.


SURVIVAL OUTSIDE HOST: Survives up to 10 days at 4o C.

SECTION V - MEDICAL

SURVEILLANCE: Monitor for symptoms-, confirm by bacterial isolation and serological tests.


FIRST AID/TREATMENT: Administer appropriate drug therapy, typically penicillin.


IMMUNIZATION: None available.


PROPHYLAXIS: None available.

SECTION VI - LABORATORY HAZARDS

LABORATORY-ACQUIRED INFECTIONS: Twenty-one cases were reported up to 1987; most were acquired by rat bites.

SOURCES/SPECIMENS: Blood, Joint fluid, or pus.

PRIMARY HAZARDS: Accidental parenteral inoculation; droplet exposure of the mucous membranes.

SPECIAL HAZARDS: Droplet generation by secretions of mouth, nose or conjunctival sac when working with infected animals.

SECTION VII - RECOMMENDED PRECAUTIONS

CONTAINMENT REQUIREMENTS: Biosafety level 2 practices and containment equipment for all activities involving bacterial cultures and potentially infectious body tissues or fluids.

PROTECTIVE CLOTHING: Laboratory coat; gloves when skin contact with infectious material is unavoidable.

OTHER PRECAUTIONS: None.

SECTION VIII - HANDLING INFORMATION

SPILLS: Allow aerosols to settle- wearing protective clothing, cover the spill with absorbent paper and apply 1% sodium hypochlorite (20% commercial bleach), starting at the perimeter and working towards the center; allow sufficient contact time (30 minutes) before clean up.

DISPOSAL: Decontaminate all wastes before disposal; steam sterilization, chemical disinfection, incineration.

STORAGE: In sealed containers that are appropriately labeled.

Date prepared: September, 1996 Prepared by: Canadian Office of Biosafety Information edited by the Colorado State University Office of Biosafety- June 16, 1998.

Back to Index